Screening for melanoma

Dermatologic Clinics

Volumn 20, Issue 4, 2002, Pages 629-640

  Geller, Alan C ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY   (United States)

^c Doctor's Office Building 801A   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; DEMOGRAPHY; DIAGNOSTIC ACCURACY; EVIDENCE BASED MEDICINE; HIGH RISK POPULATION; HUMAN; MELANOMA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SELF EXAMINATION; SKIN CANCER; SOCIAL CLASS;

FEMALE; HEALTH EDUCATION; HUMANS; INCIDENCE; MALE; MASS SCREENING; MELANOMA; PRIMARY PREVENTION; PROGNOSIS; PROGRAM DEVELOPMENT; PROGRAM EVALUATION; RISK FACTORS; SELF-EXAMINATION; SKIN NEOPLASMS; SURVIVAL ANALYSIS; UNITED STATES;

EID: 0036787447     PISSN: 07338635     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8635(02)00034-7     Document Type: Review

References (88)

1. Koh HK, Geller AC, Miller DR, Grossbart TA, Lew RA. Prevention and early detection strategies for melanoma and skin cancer. Arch Dermatol 1996;132:436-43.
2. Koh HK, Geller AC, Lew RA. Melanoma. In: Kramer BS, Gohagan JK, Prorok PC. Cancer screening theory and practice. New York: Marcel Dekker; 1999. p. 379-408.
3. Koh H, Lew R, Prout M. Screening for melanoma skin/cancer: theoretic and practical considerations. J Am Acad Dermatol 1989;20:159-75.
4. Miller A. Screening for cancer. Orlando, FL: Academic Press; 1985.
5. Davis N. Modern concepts of melanoma and its management. Ann Plast Surg 1978;1:628-9.
6. Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA. Malignant melanoma in the 1990's: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin 1991;41:201-26.
7. Howe HL, Wingo PA, Thun MJ, et al. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends. J Natl Cancer Inst 2001;93:824-42 [also accessed at www. seer.cancer.gov.].
8. Koh HK. Cutaneous melanoma. N Engl J Med 1991; 325:171-82.
9. Rigel DS. Is the ounce of screening and prevention for skin cancer worth the pound of cure? CA Cancer J Clin 1998;48:236-8.
10. Burton R, Armstrong B. Recent incidence trends imply a nonmetastasizing form of invasive melanoma. Melanoma Res 1994;4:107-13.
11. Swerlick RA, Chen S. The melanoma epidemic: is increased surveillance the solution or the problem? Arch Dermatol 1996;132:881-4.
12. Elwood JM. Screening for melanoma and options for its evaluation. J Med Screen 1994;1:22-38.
13. Andersen WK, Silvers DN. 'Melanoma'? It can't be melanoma. A subset of melanomas that defines clinical recognition. JAMA 1991;266:3463-5.
14. Koh HK, Adame N, Geller AC, et al. Cancer registry data on melanomas [letter]. N Engl J Med 1990;323: 921-2.
15. MacKie RM, Hole D. Audit of public education campaign to encourage earlier detection of malignant melanoma. BMJ 1992;304:1012-5.
16. Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL. Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996;88:17-23.
17. Burton RC, Armstrong BK. Non-metastasizing melanoma? J Surg Oncol 1998;167:180-1.
18. Albert VA, Koh HK, Geller AC, Miller DR, Prout MN, Lew RA. Years of potential life lost: another indicator of the impact of cutaneous malignant melanoma on society. J Am Acad Dermatol 1990; 23:308-10.
19. Tsao H, Rogers G, Sober A. An estimate of the annual direct cost of treating cutaneous melanoma. J Am Acad Dermatol 1998;38:669-80.
20. Aitken J. Skin cancer screening in Australia. Presented at the National Institutes of Health, Bethesda, MD, July 2001.
21. US Preventive Services Task Force. Guide to clinical preventive services. 2nd edition. Baltimore: Williams Wilkins; 1996.
22. United States Preventive Services Task Force. Screening for Skin Cancer. Am J Prev Med Special Supplement April 2001
23. Marks R, Hill D. The public health approach to melanoma control: prevention and early detection. Geneva, Switzerland: International Union Against Cancer; 1992.
24. Healthy people. National health promotion and disease prevention objectives. Washington, DC: US Department of Health and Human Services Public Health Service; 1991.
25. NIH Consensus Conference. Diagnosis and treatment of early melanoma. JAMA 1992;268:1314-9.
26. Goldsmith L, Koh HK, Bewerse B, Reilley B, Wyatt SW, Bergfeld W, et al. Proceeding from the conference to develop a national skin cancer agenda (executive summary). American Academy of Dermatology and Centers for Disease Control and Prevention. April 8-10, 1995. J Am Acad Dermatol 1996;34:822-23.
27. Institute of Medicine. Extending Medicare coverage for prevention and other services. Washington, DC: National Academy Press; 2000.
28. Rhodes AR, Weinstock MA, Fitzpatrick TB, et al. Risk factors for cutaneous melanoma: a practical method of recognizing predisposed individuals. JAMA 1987;258: 3146-54.
29. Anonymous. Boston University School of Medicine. Death rates of malignant melanoma among white men - United States, 1973-1988. MMWR Morb Mortal Wkly Rep 1992;41:20-1.
30. Hersey P, Sillar RW, Howe CG, et al. Factors related to the presentation of patients with thick primary melanomas. Med J Aust 1991;154:583-7.
31. Cooke KR, McNoe BM. Targeting early detection of malignant melanoma of the skin. N Z Med J 1991;103: 551-3.
32. Wagener DK. Patterns of melanoma deaths in the United States. Ann N Y Acad Sci 1990;609:252-6.
33. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93:678-83.
34. National Center for Health Statistics. Vital statistics mortality data multiple cause of death detail (machine-readable public use data tape). Hyattsville, MD: US Department of Health and Human Services, Public Health Service, CDC; 1997.
35. Van Durme DJ, Ferrante JM, Pal N, et al. Demographic predictors of melanoma stage at diagnosis. Arch Fam Med 2000;9:606-11.
36. Dennis LK. Increasing risk of melanoma with increasing age. JAMA 1999;282:1037-38.
37. Hanrahan PF, Hersey P, D'Este CA. Factors involved in presentation of older people with thick melanoma. Med J Aust 1998;169:410-4.
38. Kelly JW. Melanoma in the elderly: a neglected public health challenge. Med J Aust 1998;169:403-4.
39. Balch C, Soong S, Shaw H. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch C, Houghton A, Milton G, editors. Cutaneous melanoma. Philadelphia: Lippincott; 1992. p. 165-87.
40. Bonnett A, Roder D, Esterman A. Epidemiological features of melanoma in South Australia: implications for cancer control. Med J Aust 1989;151:502-9.
41. Geller AC, Miller DR, Lew RA, Clapp RW, Wenneker MB, Koh HK. Cutaneous melanoma mortality among the socioeconomically disadvantaged in Massachusetts. Am J Public Health 1996;86:538-43.
42. MacKie RM, Hole DJ. Incidence and thickness of primary tumours and survival of patients with cutaneous malignant melanoma in relation to socioeconomic status [see comments]. BMJ 1996;312:1125-8.
43. Shaw HM. Cutaneous malignant melanoma: occupation and prognosis. Med J Aust 1981;1:37-8.
44. Vagero D, Persson G. Risks, survival and trends of malignant melanoma among white and blue collar workers in Sweden. Soc Sci Med 1984;19:475-8.
45. Roetzheim RG, Pal N, Tennant C, et al. Effects of health insurance and race on early detection of cancer. J Natl Cancer Inst 1999;91:1409-15.
46. Page WF, Whiteman D, Murphy M. A comparison of melanoma mortality among WWII veterans of the Pacific and European theaters. Ann Epidemiol 2000;10: 192-5.
47. American Academy of Dermatology. Schaumburg IL.
48. Koh HK, Norton LA, Geller AC, et al. Evaluation of the American Academy of Dermatology's National Skin Cancer Early Detection and Screening Program. J Am Acad Dermatol 1996;34:971-8.
49. Geller AC, Miller DR, Halpern A. Targeting strategies for skin cancer detection in the United States [abstract]. Presented at the World Congress on Melanoma. Venice, Italy, February, 2001.
50. Koh HK, Geller AC, Miller DR, Caruso A, Gage I, Lew RA. Who is being screened for melanoma/skin cancer? J Am Acad Dermatol 1991;24:271-7.
51. Rampen FHJ, Casparie-van Velsen IJ, van Huystee BE, et al. False-negative findings in skin cancer and melanoma screening. J Am Acad Dermatol 1995;33: 59-63.
52. Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HK. Screening for malignant melanoma: a cost-effectiveness analysis. J Am Acad Dermatol 1999;41: 738-45.
53. Geller AC, Halpern AC, Sun T, et al. Participant satisfaction and value in American Academy of Dermatology and American Cancer Society skin cancer screening programs in Massachusetts. J Am Acad Dermatol 1999;40:563-6.
54. Rigel DS, Friedman RJ, Kopf AW, et al. Importance of complete cutaneous examination for the detection of malignant melanoma. J Am Acad Dermatol 1986; 14(5):857-60.
55. Jonna BP, Delfino RJ, Newman WG, Tope WD. Positive predictive value for presumptive diagnoses of skin cancer and compliance among patients attending a community screening program. Prev Med 1998;27: 611-6.
56. Rampen FHJ, van Huysteee EWL, Kiemeney LALM. Melanoma/skin cancer screening clinics: experience in the Netherlands. J Am Acad Dermatol 1991;25:776-7.
57. Hoffman K, Dirschka T, Schatz H, et al. A local education campaign on early diagnosis of malignant melanoma. Eur J Epidemiol 1993;9:591-8.
58. Engleberg D, Gallagher RP, Rivers JK. Follow-up and evaluation of skin cancer screening in British Columbia. J Am Acad Dermatol 1999;41:37-42.
59. Guibert P, Mollat F, Ligen M, Dreno B. Melanoma screening: report of a survey in occupational medicine. Arch Dermatol 2000;136:199-202.
60. Rossi CR, Vecchiato A, Bezze G, et al. Early detection of melanoma: an educational campaign in Padova, Italy. Melanoma Res 2000;10:181-7.
61. Hall HI, May DS, Lew RA, Koh HK, Nadel M. Sun protection behaviors of the US white population. Prev Med 1997;26:401-7.
62. National Center for Health Statistics. National Health Interview Survey of topics related to cancer epidemiology, 1998. Hyattsville, MD: National Center for Health Statistics; 1998.
63. Oliveria SA, Christos PJ, Halpern AC. Skin cancer screening and prevention in the primary care setting: national ambulatory medical care survey 1997. J Gen Intern Med 2001;16:297-301.
64. Weinstock MA, Martin RA, Risica PM, et al. Thorough skin examinations for the early detection of melanoma. Am J Prev Med 1999;17:169-75.
65. Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MG, Lew RA. Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol 1992;26:914-9.
66. Health US. Socioeconomic status and health chartbook. US Department of Health and Human Services, DHHS Publication Number (PHS) 98. 1998.
67. Epstein DS, Lange JR, Gruber SB, et al. Is physician detection associated with thinner melanomas? JAMA 1999;281:640-3.
68. Girgis A, Clarke P, Burton RC, Sanson-Fisher RW. Screening for melanoma by primary health care physicians: a cost-effectiveness analysis. J Med Screen 1996; 3:47-53.
69. Miller DR, Geller AC, Wyatt SW, et al. Melanoma awareness and self-examination practices: results of a United States survey. J Am Acad Dermatol 1996;34: 962-70.
70. Cassileth BR, Clark Jr. WH, Lusk EJ, Frederick BE, Thompson CJ, Walsh WP. How well do physicians recognize melanoma and other problem lesions? J Am Acad Dermatol 1986;14:555-60.
71. Geller AC, Venna S, Prout MN, Miller DR, Demierre MF, Koh HK, et al. Should the skin cancer examination be taught in medical school? Arch Dermatol 2002;138(in press, September 2002).
72. Robinson JK, McGahie WC. Skin cancer detection in clinical practice examination with standardized patients. J Am Acad Dermatol 1996;34:709-11.
73. Whited JD, Grichnik JM. Does this patient have a mole or a melanoma? JAMA 1998;279:696-701.
74. Burton RC, Howe C, Adamson L, et al. General practitioner screening for melanoma: sensitivity, specificity, and effect of training. J Med Screen 1998;5: 156-61.
75. Gerbert B, Maurer T, Berger T, Pantilat S, McPhee SJ, Wolff M, et al. Primary care physicians as gatekeepers in managed care: primary care physicians' and dermatologists' skills at secondary prevention of skin cancer. Arch Dermatol 1996;132:1030-8.
76. Masri GD, Clark Jr. WH, Guerry D, et al. Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 1990;22:1042-8.
77. Vasen HF, Bergman W, van Haeringen A, Scheffer E, van Slooten EA. The familial dysplastic nevus syndrome: natural history and the impact of screening on prognosis. A study of nine families in the Netherlands. Eur J Cancer Clin Oncol 1989;25:337-41.
78. Marghoob AA, Kopf AW, Rigel DS, et al. Risk of cutaneous malignant melanoma in patients with 'classic' atypical-mole syndrome. Arch Dermatol 1994; 130: 993-8.
79. Robinson JK, Rigel DS, Amonette RA. What promotes skin self-examination? J Am Acad Dermatol 1998;38 (part 1):752-7.
80. Baade PD, Balanda KP, Stanton WR, Gillespie AM, Lowe JB. Community perceptions about the important signs of early melanoma. J Am Acad Dermatol 1997; 36:33-9.
81. Lawson DD, Moore DH, Schneider JS, et al. Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician. J Am Acad Dermatol 1994;31:438-44.
82. Melia J, Harland C, Moss S, et al. Feasibility of targeted early detection for melanoma: a population-based screening study. Br J Cancer 2000;82: 1605-9.
83. Hanrahan PF, Menzies SW, D'Este CA, et al. Participation of older males in a study on photography as an aid to early detection of melanoma. Aust N Z J Public Health 2000;24:615-8.
84. Jackson A, Wilkinson C, Pill R. Moles and melanoma: who's at risk, who knows, and who cares? A strategy to inform those at high risk. Br J Gen Pract 1999;49: 199-203.
85. Gerbert B, Bronstone A, Wolff M, Maurer T, Berger T, Pantilat S, et al. Improving primary care residents' proficiency in the diagnosis of skin cancer. J Gen Intern Med 1998;13:91-7.
86. Dolan NC, Martin GJ, Robinson JK, Rademaker AW. Skin cancer control practices among physicians in a university general medicine practice. J Gen Intern Med 1995;10:515-9.
87. McCormick L, Masse L, Cummings S, Burke C. Evaluation of a skin cancer prevention module for nurses: change in knowledge, self-efficacy, and attitudes. Am J Health Promot 1999;13:282-9.
88. Oliveria SA, Nehal KS, Christos PJ, et al. Using nurse practitioners for skin cancer screening: a pilot study. Am J Prev Med 2001;21:214-7.